Announcement

Collapse
No announcement yet.

J Clin Pharm Ther . SARS-CoV-2 neutralizing antibodies for COVID-19: Outcomes for bamlanivimab versus bamlanivimab-etesevimab combination in a racially diverse cohort of patients with significant comorbidities

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
    No photos found.
Working...
X